Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec;17(4):210110.
doi: 10.1183/20734735.0110-2021.

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Lauren A Quinn  1 , Sunaya H Hirani  2 , Thomas C Williams  3   4   5 , Ian P Sinha  2   6   5
Affiliations
Editorial

Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Lauren A Quinn et al. Breathe (Sheff). 2021 Dec.

Abstract

It is uncertain whether immunoprophylaxis against RSV protects preterm babies with BPD against future respiratory problems. It is biologically plausible that it does, at least in some infants. https://bit.ly/3ikzwZD.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: I.P Sinha, S.H. Hirani, and L.A. Quinn have no interests to declare. T.C. Williams sits on the Laboratory Technical Committee for Phase 2 of the WHO Global RSV Surveillance Programme.

Comment on

References

    1. Bui DS, Lodge CJ, Burgess JA, et al. . Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med 2018; 6: 535–544.doi:10.1016/S2213-2600(18)30100-0 - DOI - PubMed
    1. Belgrave DCM, Granell R, Turner SW, et al. . Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies. Lancet Respir Med 2018; 6: 526–534.doi:10.1016/S2213-2600(18)30099-7 - DOI - PubMed
    1. Dassios T, Greenough A. Long-term sequelae of bronchopulmonary dysplasia. In: Sinha IP, Bhatt JM, Cleator A, et al., eds. Respiratory Diseases of the Newborn Infant. Sheffield, European Respiratory Society, 2021; 68–78. doi:10.1183/2312508X.erm9221 - DOI
    1. Rose K, Woodland C, Murphy G, et al. . Management of bronchopulmonary dysplasia: strategies to prevent short- and long-term complications following discharge from the NICU. In: Sinha IP, Bhatt JM, Cleator A, et al., eds. Respiratory Diseases of the Newborn Infant. Sheffield, European Respiratory Society, 2021; 79–88. doi:10.1183/2312508X.erm9221 - DOI
    1. Glezen WP. Risk of primary infection and reinfection with respiratory syncytial virus. Arch Pediatr Adolesc Med 1986; 140: 543. doi:10.1001/archpedi.1986.02140200053026 - DOI - PubMed

LinkOut - more resources